Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Seagen Inc.
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
Merus B.V.
Tizona Therapeutics, Inc
University of California, San Diego
BioNTech SE
IDEAYA Biosciences
Washington University School of Medicine
Merck Sharp & Dohme LLC
University of California, San Diego
UNC Lineberger Comprehensive Cancer Center
Wake Forest University Health Sciences
VLP Therapeutics
Novartis
University of Chicago
VM Oncology, LLC
Groupe Oncologie Radiotherapie Tete et Cou
Incyte Corporation
University of Chicago
Inhibrx Biosciences, Inc
Astellas Pharma Inc
University of Cincinnati
Sanford Health
Maastricht University Medical Center
University of Chicago
PDS Biotechnology Corp.
BioAtla, Inc.
Hokkaido University Hospital
Hookipa Biotech GmbH
Bicara Therapeutics
MacroGenics
Incyte Corporation
ALX Oncology Inc.
ALX Oncology Inc.
Ascendis Pharma A/S
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Hookipa Biotech GmbH
DEKA Biosciences
M.D. Anderson Cancer Center
Rapa Therapeutics LLC
Regeneron Pharmaceuticals
Beijing Tongren Hospital
University of Pittsburgh
Intensity Therapeutics, Inc.
Dana-Farber Cancer Institute
Alentis Therapeutics AG